142 related articles for article (PubMed ID: 1717122)
1. Clinical significance of CD7-positive stem cell leukemia. A distinct subtype of mixed lineage leukemia.
Yumura-Yagi K; Hara J; Kurahashi H; Okamura J; Koizumi S; Toyoda Y; Murayama N; Inoue M; Ishihara S; Tawa A
Cancer; 1991 Nov; 68(10):2273-80. PubMed ID: 1717122
[TBL] [Abstract][Full Text] [Related]
2. Lineage determination of CD7+ CD5- CD2- and CD7+ CD5+ CD2- lymphoblasts: studies on phenotype, genotype, and gene expression of myeloperoxidase, CD3 epsilon, and CD3 delta.
Yoneda N; Tatsumi E; Teshigawara K; Nagata S; Nagano T; Kishimoto Y; Kimura T; Yasunaga K; Yamaguchi N
Am J Hematol; 1994 Apr; 45(4):310-20. PubMed ID: 7513945
[TBL] [Abstract][Full Text] [Related]
3. Characterization of acute myeloid leukemia (AML) coexpressing lymphoid markers: different biologic features between T-cell antigen positive and B-cell antigen positive AML.
Tien HF; Wang CH; Chen YC; Shen MC; Lin DT; Lin KH
Leukemia; 1993 May; 7(5):688-95. PubMed ID: 8483320
[TBL] [Abstract][Full Text] [Related]
4. Acute undifferentiated leukemia with CD7+ and CD13+ immunophenotype. Lack of molecular lineage commitment and association with poor prognostic features.
Bassan R; Biondi A; Benvestito S; Tini ML; Abbate M; Viero P; Barbui T; Rambaldi A
Cancer; 1992 Jan; 69(2):396-404. PubMed ID: 1370211
[TBL] [Abstract][Full Text] [Related]
5. Molecular analysis of acute undifferentiated leukemia: two distinct subgroups at the DNA and RNA levels.
Hara J; Yumura-Yagi K; Tawa A; Ishihara S; Murata M; Terada N; Izumi Y; Champagne E; Takihara Y; Mak TW
Blood; 1989 Oct; 74(5):1738-46. PubMed ID: 2790199
[TBL] [Abstract][Full Text] [Related]
6. T-stem cell leukemia/lymphoma with both myeloid lineage conversion and T-specific delta recombination.
Nagano M; Kimura N; Akiyoshi T; Nishimura J; Kozuru M; Okamura J; Katsuno M; Yoshida T; Takeshita M; Tachibana K; Ohshima K; Kikuchi M
Leuk Res; 1997 Aug; 21(8):763-73. PubMed ID: 9379684
[TBL] [Abstract][Full Text] [Related]
7. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
8. Lineage commitment in biphenotypic acute leukemia.
Buccheri V; Matutes E; Dyer MJ; Catovsky D
Leukemia; 1993 Jun; 7(6):919-27. PubMed ID: 8501986
[TBL] [Abstract][Full Text] [Related]
9. CD7+ and CD56+ myeloid/natural killer cell precursor acute leukemia: a distinct hematolymphoid disease entity.
Suzuki R; Yamamoto K; Seto M; Kagami Y; Ogura M; Yatabe Y; Suchi T; Kodera Y; Morishima Y; Takahashi T; Saito H; Ueda R; Nakamura S
Blood; 1997 Sep; 90(6):2417-28. PubMed ID: 9310493
[TBL] [Abstract][Full Text] [Related]
10. Configuration of immunoglobulin and T cell receptor beta and gamma genes in acute myeloid leukaemia: pitfalls in the analysis of 40 cases.
Parreira L; Carvalho C; Moura H; Melo A; Santos P; Guimarães JE; Parreira A
J Clin Pathol; 1992 Mar; 45(3):193-200. PubMed ID: 1372916
[TBL] [Abstract][Full Text] [Related]
11. T lymphoid/myeloid bilineal crisis in chronic myelogenous leukemia.
Akashi K; Mizuno S; Harada M; Kimura N; Kinjyo M; Shibuya T; Shimoda K; Takeshita M; Okamura S; Matsumoto I
Exp Hematol; 1993 Jun; 21(6):743-8. PubMed ID: 7684698
[TBL] [Abstract][Full Text] [Related]
12. CD7+ stem cell leukemia/lymphoma. Features of a subgroup without circulating blast cells.
Katsuno M; Abe Y; Taguchi F; Yufu Y; Sadamura S; Goto T; Takatsuki H; Nishimura J; Hirata J; Akiyoshi T
Cancer; 1993 Jul; 72(1):99-104. PubMed ID: 7685244
[TBL] [Abstract][Full Text] [Related]
13. Heterogeneity of CD7+ 4- 8- 1- leukemia: usefulness of cytoplasmic antigen detection for subclassification.
Masuda M; Arai Y; Osawa M; Kaneko T; Aoyama M; Motoji T; Oshimi K; Mizoguchi H
Leukemia; 1993 Nov; 7(11):1759-65. PubMed ID: 7694004
[TBL] [Abstract][Full Text] [Related]
14. High prevalence of T cell receptor D delta 2(D delta)J delta rearrangement in CD7-positive early T cell acute lymphoblastic leukemia.
Kimura N; Akiyoshi T; Uchida T; Okamura J; Kozuru M; Nishimura J; Ohyashiki JH; Kikuchi M; Niho Y; Okumura M
Leukemia; 1996 Apr; 10(4):650-7. PubMed ID: 8618442
[TBL] [Abstract][Full Text] [Related]
15. Characterization of CD7+CD19+ lymphoid cells after Epstein-Barr virus transformation.
Panzer-Grümayer ER; Panzer S; Wolf M; Majdic O; Haas OA; Kersey JH
J Immunol; 1993 Jul; 151(1):92-9. PubMed ID: 7686950
[TBL] [Abstract][Full Text] [Related]
16. A subset of acute nonlymphocytic leukemia with expression of surface antigen CD7--morphologic, cytochemical, immunocytochemical and T cell receptor gene analysis on 13 patients.
Tien HF; Wang CH; Su IJ; Liu FS; Wu HS; Chen YC; Lin KH; Lee SC; Shen MC
Leuk Res; 1990; 14(6):515-23. PubMed ID: 1695699
[TBL] [Abstract][Full Text] [Related]
17. CD7, CD34-positive stem cell leukemia arising in agnogenic myeloid metaplasia.
Tasaka T; Nagai M; Murao S; Yamaguchi M; Kitanaka A; Sasaki K; Murata M; Tanaka T; Kuwabara H; Ikeda K
Am J Hematol; 1993 Sep; 44(1):53-7. PubMed ID: 7688180
[TBL] [Abstract][Full Text] [Related]
18. CD7 expression in acute myeloid leukemia.
Del Poeta G; Stasi R; Venditti A; Cox C; Aronica G; Masi M; Bruno A; Simone MD; Buccisano F; Papa G
Leuk Lymphoma; 1995 Mar; 17(1-2):111-9. PubMed ID: 7539657
[TBL] [Abstract][Full Text] [Related]
19. CD7+ TdT+ chronic myelogenous leukemia blast crisis with null genotype.
Smith MR; Mohamed AN; Karanes C
Leukemia; 1993 Feb; 7(2):177-80. PubMed ID: 7678877
[TBL] [Abstract][Full Text] [Related]
20. Mixed phenotype acute leukemia with t(11;19)(q23;p13.3)/ MLL-MLLT1(ENL), B/T-lymphoid type: A first case report.
Naghashpour M; Lancet J; Moscinski L; Zhang L
Am J Hematol; 2010 Jun; 85(6):451-4. PubMed ID: 20513125
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
